| Hereditary hemochromatosis with homozygous C282Y HFE mutation: possible clinical model to assess effects of elevated reactive oxygen species on the development of cardiovascular disease. | Hereditary hemochromatosis with homozygous C282Y HFE mutation: possible clinical model to assess effects of elevated reactive oxygen species on the development of cardiovascular disease.
Shizukuda Y, Rosing DR. | 04/4/2024 |
| HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank. | HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank.
Lucas MR, Atkins JL, Pilling LC, Shearman JD, Melzer D., Free PMC Article | 03/15/2024 |
| Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study. | Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study.
Schaefer B, Pammer LM, Pfeifer B, Neururer S, Troppmair MR, Panzer M, Wagner S, Pertler E, Gieger C, Kronenberg F, Lamina C, Tilg H, Zoller H. | 03/1/2024 |
| Height of non-Hispanic white adults with homeostatic iron regulator HFE genotypes p.C282Y/p.C282Y and wt/wt. | Height of non-Hispanic white adults with homeostatic iron regulator HFE genotypes p.C282Y/p.C282Y and wt/wt.
Barton JC, Barton JC, Acton RT., Free PMC Article | 01/31/2024 |
| Risk Effects of rs1799945 Polymorphism of the HFE Gene and Intergenic Interactions of GWAS-Significant Loci for Arterial Hypertension in the Caucasian Population of Central Russia. | Risk Effects of rs1799945 Polymorphism of the HFE Gene and Intergenic Interactions of GWAS-Significant Loci for Arterial Hypertension in the Caucasian Population of Central Russia.
Ivanova T, Churnosova M, Abramova M, Ponomarenko I, Reshetnikov E, Aristova I, Sorokina I, Churnosov M., Free PMC Article | 05/22/2023 |
| Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. | Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
Natarajan Y, Patel P, Chu J, Yu X, Hernaez R, El-Serag H, Kanwal F. | 02/4/2023 |
| A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population. | A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population.
Hubacek JA, Philipp T, Adamkova V, Majek O, Dusek L., Free PMC Article | 02/4/2023 |
| Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment. | Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
Infanti L, Leitner G, Moe MK, Pehlic V, Benkert P, Cattaneo M, Holbro A, Passweg J, Worel N, Buser A. | 10/22/2022 |
| Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review. | Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review.
Gromadzka G, Wierzbicka DW, Przybyłkowski A, Litwin T. | 08/27/2022 |
| Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes. | Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes.
Dissanayake R, Samarasinghe N, Waidyanatha S, Pathirana S, Neththikumara N, Dissanayake VHW, Wetthasinghe K, Gooneratne L, Wickramasinghe P., Free PMC Article | 06/25/2022 |
| An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people. | An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people.
Zanella I, Zacchi E, Fornari C, Fumarola B, Antoni MD, Zizioli D, Quiros-Roldan E, Inflammation in H. I. V. Study Group., Free PMC Article | 05/28/2022 |
| Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache. | Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache.
Papasavva M, Vikelis M, Katsarou MS, Siokas V, Dermitzakis E, Papademetriou C, Karakostis K, Lazopoulos G, Dardiotis E, Drakoulis N., Free PMC Article | 04/9/2022 |
| Common and rare variants in HFE are not associated with Parkinson's disease in Europeans. | Common and rare variants in HFE are not associated with Parkinson's disease in Europeans.
Saini P, Bandres-Ciga S, Alcantud JL, Ruz C, Postuma RB, Gan-Or Z, International Parkinson's disease Genomics Consortium., Free PMC Article | 03/19/2022 |
| Elevated transferrin saturation in individuals with alcohol use disorder: Association with HFE polymorphism and alcohol withdrawal severity. | Elevated transferrin saturation in individuals with alcohol use disorder: Association with HFE polymorphism and alcohol withdrawal severity.
Kroll DS, McPherson KL, Manza P, Schwandt ML, Shen PH, Goldman D, Diazgranados N, Wang GJ, Wiers CE, Volkow ND., Free PMC Article | 03/5/2022 |
| Severe iron overload in a woman with homeostatic iron regulator (HFE) and a novel 5'-aminolevulinate synthase 2 (ALAS2) mutations: interactions of multiple genetic determinants. | Severe iron overload in a woman with homeostatic iron regulator (HFE) and a novel 5'-aminolevulinate synthase 2 (ALAS2) mutations: interactions of multiple genetic determinants.
de Gennes C, Lamoril J, Borgel A, Boi C, Yao R, Boileau C, Tchernitchko D. | 02/19/2022 |
| Erythropoietin Concentration in Boys With p.His63Asp Polymorphism of the HFE Gene. | Erythropoietin Concentration in Boys With p.His63Asp Polymorphism of the HFE Gene.
Kaczorowska-Hac B, Luszczyk M, Wasilewska E, Antosiewicz J, Kaczor JJ. | 02/19/2022 |
| HFE Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis. | HFE Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis.
Sandnes M, Vorland M, Ulvik RJ, Reikvam H., Free PMC Article | 02/12/2022 |
| Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study. | Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study.
Dawood RM, Abd El Meguid M, Elrobe W, Salum GM, Zayed N, Mousa S, Medhat E., Free PMC Article | 12/25/2021 |
| HFE variants in colorectal cancer and their clinicopathological correlations. | HFE variants in colorectal cancer and their clinicopathological correlations.
Kodagoda Gamage SM, Islam F, Cheng T, Aktar S, Lu CT, Ranaweera CD, Lee KTW, Dissabandara L, Gopalan V, Lam AK. | 12/25/2021 |
| Whole-body R2 * mapping to quantify tissue iron in iron storage organs: reference values and a genotype. | Whole-body R2∗ mapping to quantify tissue iron in iron storage organs: reference values and a genotype.
Kromrey ML, Röhnert A, Blum S, Winzer R, Hoffman RT, Völzke H, Kacprowski T, Kühn JP. | 12/18/2021 |
| Molecular analysis of homeostatic iron regulator, transmembrane protease serine-6, and BTB domain-containing protein-9 variants and iron parameters in blood donors. | Molecular analysis of homeostatic iron regulator, transmembrane protease serine-6, and BTB domain-containing protein-9 variants and iron parameters in blood donors.
Fawzy MS, Fakhr-Eldeen A, Abu AlSel BT, Toraih EA., Free PMC Article | 12/18/2021 |
| Urinary Neutrophil Gelatinase-Associated Lipocalin/Hepcidin-25 Ratio for Early Identification of Patients at Risk for Renal Replacement Therapy After Cardiac Surgery: A Substudy of the BICARBONATE Trial. | Urinary Neutrophil Gelatinase-Associated Lipocalin/Hepcidin-25 Ratio for Early Identification of Patients at Risk for Renal Replacement Therapy After Cardiac Surgery: A Substudy of the BICARBONATE Trial.
Elitok S, Kuppe H, Devarajan P, Bellomo R, Isermann B, Westphal S, Kube J, Albert C, Ernst M, Kropf S, Haase-Fielitz A, Haase M. | 12/4/2021 |
| HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity. | HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity.
Vaitiekus D, Muckiene G, Vaitiekiene A, Sereikaite L, Inciuraite R, Insodaite R, Cepuliene D, Kupcinskas J, Ugenskiene R, Jurkevicius R, Juozaityte E. | 12/4/2021 |
| Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE. | Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE.
Bardou-Jacquet E, Morandeau E, Anderson GJ, Ramm GA, Ramm LE, Morcet J, Bouzille G, Dixon J, Clouston AD, Lainé F, Turlin B, Powell LW, Deugnier YM. | 09/18/2021 |
| HIF1A: A Putative Modifier of Hemochromatosis. | HIF1A: A Putative Modifier of Hemochromatosis.
Pelucchi S, Ravasi G, Arosio C, Mauri M, Piazza R, Mariani R, Piperno A., Free PMC Article | 09/11/2021 |